Scientific article

Prise en charde du carcinome hépatocellulaire en 2010

Published inRevue médicale suisse, vol. 6, no. 233, p. 198-202
Publication date2010

Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors worldwide and its incidence has increased over the last years in most developed countries. The majority of HCCs occur in the context of liver cirrhosis. Therefore, patients with cirrhosis and those with hepatitis B virus infection should enter a surveillance program. Detection of a focal liver lesion by ultrasound should be followed by further investigations to confirm the diagnosis and to permit staging. A number of curative and palliative treatment options are available today. The choice of treatment will depend on the tumor stage, liver function and the presence of portal hypertension as well as the general condition of the patient. A multidisciplinary approach is mandatory to offer to each patient the best treatment.

  • Carcinoma, Hepatocellular/epidemiology/pathology/therapy
  • Chemoembolization, Therapeutic
  • Humans
  • Liver Neoplasms/epidemiology/pathology/therapy
  • Liver Transplantation
  • Risk Factors
Citation (ISO format)
PACHE, Isabelle et al. Prise en charde du carcinome hépatocellulaire en 2010. In: Revue médicale suisse, 2010, vol. 6, n° 233, p. 198–202.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation10/17/2013 2:57:00 PM
First validation10/17/2013 2:57:00 PM
Update time03/14/2023 8:34:02 PM
Status update03/14/2023 8:34:01 PM
Last indexation08/29/2023 7:06:39 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack